OrganiGram Holdings Inc trades with the ticker OGI on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.
Overview
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
Looking to invest in OrganiGram Holdings Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
OGI.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $256.887MM
PE Ratio:
Price: 1.95 (Updated: 3/12/2024 0:47:16)
OrganiGram Holdings Inc (OGI) vs Competitors in Drug Manufacturers – Specialty & Generic
Lets see how OGI.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:Aurora Cannabis Inc, Avicanna Inc, Bausch Health Companies Inc, Cardiol Therapeutics Inc, Cronos Group Inc
.Drug Manufacturers – Specialty & Generic Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aurora Cannabis Inc (ACB) | $222.521 | N/A | -0.115 | N/A% |
| Avicanna Inc (AVCN) | $43.759 | N/A | -4.217 | N/A% |
| Bausch Health Companies Inc (BHC) | $4,553.034 | N/A | 15.169 | N/A% |
| Cardiol Therapeutics Inc (CRDL) | $132.181 | N/A | -3.0 | N/A% |
| Cronos Group Inc (CRON) | $1,018.068 | N/A | 1.918 | N/A% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Drug Manufacturers – Specialty & Generic
- OrganiGram Holdings Inc (OGI) vs Aurora Cannabis Inc (ACB)
- OGI has higher EPS (-2.51 vs -79.2). ACB and OGI both have P/E’s under 0.
- OrganiGram Holdings Inc (OGI) vs Avicanna Inc (AVCN)
- AVCN has higher EPS (-0.17 vs -2.51). AVCN and OGI both have P/E’s under 0.
- OrganiGram Holdings Inc (OGI) vs Bausch Health Companies Inc (BHC)
- BHC has higher EPS (-2.18 vs -2.51). BHC and OGI both have P/E’s under 0.
- OrganiGram Holdings Inc (OGI) vs Cardiol Therapeutics Inc (CRDL)
- CRDL has higher EPS (-0.43 vs -2.51). CRDL and OGI both have P/E’s under 0.
- OrganiGram Holdings Inc (OGI) vs Cronos Group Inc (CRON)
- CRON has higher EPS (-0.24 vs -2.51). CRON and OGI both have P/E’s under 0.
Our Recommendation: Hold
Shows positive EPS growth from this year to next, suggesting improving profitability. Features a lower EV/EBITDA ratio (-1.10) than the industry average (0.33), indicating attractive valuation.
How to Buy OGI stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
